141 related articles for article (PubMed ID: 16728689)
21. TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells.
Nee L; Tuite N; Ryan MP; McMorrow T
Nephron Exp Nephrol; 2007; 107(2):e73-86. PubMed ID: 17890880
[TBL] [Abstract][Full Text] [Related]
22. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Anand SP; Selvaraj P
Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
[TBL] [Abstract][Full Text] [Related]
23. Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10.
Beeh KM; Beier J; Kornmann O; Micke P; Buhl R
J Heart Lung Transplant; 2001 Nov; 20(11):1144-51. PubMed ID: 11704473
[TBL] [Abstract][Full Text] [Related]
24. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10.
Waehre T; Halvorsen B; Damås JK; Yndestad A; Brosstad F; Gullestad L; Kjekshus J; Frøland SS; Aukrust P
Eur J Clin Invest; 2002 Nov; 32(11):803-10. PubMed ID: 12423320
[TBL] [Abstract][Full Text] [Related]
26. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
Korem S; Resnick MB; Kraiem Z
J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
[TBL] [Abstract][Full Text] [Related]
27. High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
Elmas E; Lang S; Dempfle CE; Kälsch T; Hannak D; Sueselbeck T; Wolpert C; Borggrefe M; Brueckmann M
Clin Chem Lab Med; 2007; 45(10):1360-5. PubMed ID: 17727318
[TBL] [Abstract][Full Text] [Related]
28. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells.
Nee LE; McMorrow T; Campbell E; Slattery C; Ryan MP
Kidney Int; 2004 Oct; 66(4):1376-86. PubMed ID: 15458430
[TBL] [Abstract][Full Text] [Related]
29. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
Hoseini SM; Kalantari A; Afarideh M; Noshad S; Behdadnia A; Nakhjavani M; Esteghamati A
Metabolism; 2015 Apr; 64(4):527-38. PubMed ID: 25633268
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
[TBL] [Abstract][Full Text] [Related]
32. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Lorenzl S; Buerger K; Hampel H; Beal MF
Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
[TBL] [Abstract][Full Text] [Related]
33. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
34. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
[TBL] [Abstract][Full Text] [Related]
35. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
36. TIMP-1 mediates the inhibitory effect of interleukin-6 on the proliferation of a hepatocarcinoma cell line in a STAT3-dependent manner.
Guo SY; Shen X; Yang J; Yuan J; Yang RL; Mao K; Zhao DH; Li CJ
Braz J Med Biol Res; 2007 May; 40(5):621-31. PubMed ID: 17464423
[TBL] [Abstract][Full Text] [Related]
37. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
38. Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels.
Wong WR; Kossodo S; Kochevar IE
J Formos Med Assoc; 2001 Jun; 100(6):377-82. PubMed ID: 11480246
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
40. The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.
Holven KB; Aukrust P; Retterstøl K; Otterdal K; Bjerkeli V; Ose L; Nenseter MS; Halvorsen B
J Nutr; 2008 Nov; 138(11):2070-5. PubMed ID: 18936200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
